Table 5.
Studies | Year | Dosage | Proposed mechanism |
---|---|---|---|
Yang et al. [14] | 2016 | 10 μmol/L | Upregulation of VEGF-B signaling, attenuate oxidative stress (ROS, MnSOD) |
Liao et al. [15] | 2014 | 2.0 mg/kg d | Upregulation of VDAC1 signaling, inhibit mitochondria-mediated apoptosis (mPTP, caspase-3, cytochrome c) |
Adam et al. [16] | 2012 | 10 mmol/L | SIRT1-independent |
Mukhopadhyay et al. [33] | 2010 | 5 mg/kg/d | Regulation of miRNA expression (miR-21) |
Lekli et al. [34] | 2009 | 2.5 mg/kg/d | Regulation of autophagy |
Das et al. [35] | 2006 | 10 μmol/L | Activation of MAPK (ERK 1/2, p38 MAPK)/MSK1/CREB signaling, antiapoptosis |
Ray et al. [36] | 1999 | 10 μmol/L | Attenuate oxidative stress (MDA) |